Glial fibrillary acidic protein in the cerebrospinal fluid of patients with dementia

被引:60
作者
Wallin, A
Blennow, K
Rosengren, LE
机构
[1] GOTHENBURG UNIV, DEPT PSYCHIAT & NEUROCHEM, S-41124 GOTHENBURG, SWEDEN
[2] GOTHENBURG UNIV, DEPT ANAT & CELL BIOL, S-41124 GOTHENBURG, SWEDEN
来源
DEMENTIA | 1996年 / 7卷 / 05期
关键词
glial fibrillary acidic protein; cerebrospinal fluid; Alzheimer's disease; vascular dementia; frontal lobe dementia;
D O I
10.1159/000106891
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Glial fibrillary acidic protein (GFAP) is the structural protein of the astroglial intermediate filament that forms the morphological basis of astrogliosis. In the present study, GFAP concentrations in cerebrospinal fluid were measured in patients with various dementia diseases. A significant correlation between GFAP and age was found both in the total dementia group and in the controls. Covariance analysis with GFAP as dependent variable and age and albumin ratio as covariates followed by multiple group comparisons showed that, with regard to GFAP levels, the controls (n = 39) differed significantly from the patients with vascular dementia (n = 20; p < 0.05), senile dementia of the Alzheimer type (n = 29; p < 0.05), and 'pure' Alzheimer's disease (n = 8; p < 0.05), but not from those with frontal lobe dementia (n = 5).
引用
收藏
页码:267 / 272
页数:6
相关论文
共 57 条
[1]   DETERMINATION OF S-100 AND GLIAL FIBRILLARY ACIDIC PROTEIN CONCENTRATIONS IN CEREBROSPINAL-FLUID AFTER BRAIN INFARCTION [J].
AURELL, A ;
ROSENGREN, LE ;
KARLSSON, B ;
OLSSON, JE ;
ZBORNIKOVA, V ;
HAGLID, KG .
STROKE, 1991, 22 (10) :1254-1258
[2]   BINSWANGERS DISEASE - A REVIEW [J].
BABIKIAN, V ;
ROPPER, AH .
STROKE, 1987, 18 (01) :2-12
[3]   PATTERNS OF GLIOSIS IN ALZHEIMERS-DISEASE AND AGING CEREBRUM [J].
BEACH, TG ;
WALKER, R ;
MCGEER, EG .
GLIA, 1989, 2 (06) :420-436
[4]   ASTROGLIAL RESPONSE TO STABBING - IMMUNOFLUORESCENCE STUDIES WITH ANTIBODIES TO ASTROCYTE-SPECIFIC PROTEIN (GFA) IN MAMMALIAN AND SUB-MAMMALIAN VERTEBRATES [J].
BIGNAMI, A ;
DAHL, D .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1976, 2 (02) :99-110
[5]  
BLENNOW K, 1990, ACTA NEUROL SCAND, V81, P323
[6]  
Blennow K, 1992, J Geriatr Psychiatry Neurol, V5, P106
[7]   GANGLIOSIDES IN CEREBROSPINAL-FLUID IN PROBABLE ALZHEIMERS-DISEASE [J].
BLENNOW, K ;
DAVIDSSON, P ;
WALLIN, A ;
FREDMAN, P ;
GOTTFRIES, CG ;
KARLSSON, I ;
MANSSON, JE ;
SVENNERHOLM, L .
ARCHIVES OF NEUROLOGY, 1991, 48 (10) :1032-1035
[8]   WHITE-MATTER LESIONS ON CT IN ALZHEIMER PATIENTS - RELATION TO CLINICAL SYMPTOMATOLOGY AND VASCULAR FACTORS [J].
BLENNOW, K ;
WALLIN, A ;
UHLEMANN, C ;
GOTTFRIES, CG .
ACTA NEUROLOGICA SCANDINAVICA, 1991, 83 (03) :187-193
[9]   The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder [J].
Bouffard, R ;
Hechtman, L ;
Minde, K ;
Iaboni-Kassab, F .
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2003, 48 (08) :546-554
[10]  
BRIERLEY JB, 1984, GREENFIELDS NEUROPAT, P125